# FDA Inspection 1031001 - S&B Pharma LLC - October 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/sb-pharma-llc/cce8c698-04d8-4625-9d73-df23eabd4a74
Source feed: FDA_Inspections

> FDA Inspection 1031001 for S&B Pharma LLC on October 27, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031001
- Company Name: S&B Pharma LLC
- Inspection Date: 2017-10-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1172319 - 2022-06-17](https://www.keypedia.com/records/fda_inspections/sb-pharma-llc/54963e8d-afba-4cf5-9cca-7a0646d7796f)
- [FDA Inspection 1121238 - 2020-02-06](https://www.keypedia.com/records/fda_inspections/sb-pharma-llc/0da4c659-a5f7-48b1-a05e-195dc1cc6e4c)
- [FDA Inspection 1047928 - 2018-03-16](https://www.keypedia.com/records/fda_inspections/sb-pharma-llc/9d542333-9374-409a-93d6-381f4b1aa795)
- [FDA Inspection 915801 - 2015-02-26](https://www.keypedia.com/records/fda_inspections/sb-pharma-llc/e9e7629c-7ee2-45fb-8c1e-485b857fc796)
- [FDA Inspection 860661 - 2013-11-19](https://www.keypedia.com/records/fda_inspections/sb-pharma-llc/f6dec050-205e-473c-baf2-b859c1602dd7)

Company: https://www.keypedia.com/companies/sb-pharma-llc/232b2ea9-4ea7-41e2-aed7-7b885ca80003

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c